医学
风险评估
阿司匹林
内科学
冠状动脉钙
弗雷明翰风险评分
心脏病学
临床试验
冠状动脉疾病
重症监护医学
他汀类
疾病
动脉粥样硬化性心血管疾病
计算机安全
计算机科学
作者
Philip Greenland,Donald M. Lloyd‐Jones
出处
期刊:JAMA Cardiology
[American Medical Association]
日期:2021-10-09
卷期号:7 (2): 219-219
被引量:35
标识
DOI:10.1001/jamacardio.2021.3948
摘要
This narrative review summarizes the evidence available about the appropriate role of CAC testing for ASCVD risk assessment. Coronary artery calcium testing should be used selectively in patients who are at intermediate risk of ASCVD, when there is persistent uncertainty after performing standard risk assessment using traditional risk factors in a risk score, and after consideration of additional individual risk-enhancing factors. In these situations, the result of the CAC test can be helpful to clarify whether the patient's true risk is high enough to justify initiation of primary prevention medications, such as statins or aspirin.
科研通智能强力驱动
Strongly Powered by AbleSci AI